investorscraft@gmail.com

Intrinsic ValueFureasu Co.,Ltd. (7062.T)

Previous Close¥811.00
Intrinsic Value
Upside potential
Previous Close
¥811.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Fureasu Co., Ltd. operates in Japan's personal services sector, specializing in massage and home healthcare services. The company generates revenue through a diversified portfolio, including home acupuncture, moxibustion massage, and in-home nursing care, catering to both individual and institutional clients. Its franchise model for massage services enhances scalability, while its focus on accessibility—such as support for the visually impaired—differentiates it in a competitive market. Fureasu also provides medical care facility management and home care services, positioning itself as an integrated wellness and healthcare provider. The company’s multi-functional approach, combining traditional therapies with modern care solutions, allows it to serve aging populations and urban professionals seeking convenience. Despite operating in a fragmented industry, Fureasu’s established brand and localized service network strengthen its regional market share.

Revenue Profitability And Efficiency

Fureasu reported revenue of JPY 5.71 billion for FY 2024, with net income of JPY 58.3 million, reflecting modest profitability in a labor-intensive sector. Operating cash flow stood at JPY 172 million, though capital expenditures of JPY -125 million indicate ongoing investments in service infrastructure. The company’s asset-light franchise model likely contributes to manageable operational costs, but margin pressures from wage inflation or regulatory changes remain a risk.

Earnings Power And Capital Efficiency

Diluted EPS of JPY 24.55 suggests limited but stable earnings power, supported by recurring service demand. The balance between franchise fees and direct service revenue may enhance capital efficiency, though high debt levels (JPY 3.48 billion) relative to cash (JPY 1.13 billion) could constrain financial flexibility. Further scrutiny of ROIC would clarify capital allocation effectiveness.

Balance Sheet And Financial Health

The company holds JPY 1.13 billion in cash against total debt of JPY 3.48 billion, indicating leveraged financial positioning. While current liquidity appears adequate, the debt-to-equity ratio warrants monitoring, especially given the capital-intensive nature of healthcare services. Positive operating cash flow provides some buffer for debt servicing.

Growth Trends And Dividend Policy

Growth prospects hinge on Japan’s aging demographics and demand for home healthcare. A dividend of JPY 21.14 per share signals commitment to shareholder returns, though payout sustainability depends on stabilizing profitability. Expansion into underserved regions or digital health integrations could drive future revenue streams.

Valuation And Market Expectations

With a market cap of JPY 1.79 billion and a beta of 0.315, Fureasu is perceived as a low-volatility play in defensive sectors. The valuation likely reflects modest growth expectations and sector-specific risks, such as labor shortages or reimbursement policy changes.

Strategic Advantages And Outlook

Fureasu’s niche in integrated wellness and franchised services offers resilience against economic cycles. Strategic partnerships or technology adoption could enhance scalability, while regulatory tailwinds in elderly care may support long-term demand. However, execution risks and competitive pressures necessitate cautious optimism.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount